奥美沙坦
化学
药理学
药品
敌手
血管紧张素II受体拮抗剂
血管紧张素受体
血管紧张素II
组合化学
受体
内科学
生物化学
医学
血压
作者
Karrothu Srihari Babu,Amirisetty Ravindranath Tagore,Gade S. Reddy,Gandu Venkateswarlu,Padi Pratap Reddy,Ramasamy Vijaya Anand
出处
期刊:Arkivoc
[ARKAT USA, Inc.]
日期:2010-05-31
卷期号:2010 (2): 292-302
被引量:14
标识
DOI:10.3998/ark.5550190.0011.224
摘要
Olmesartan medoxomil 1 is the latest angiotensin receptor antagonist approved by the FDA for the treatment of hypertension.During the process development of olmesartan medoxomil, four related substances (impurities) were observed along with the final API.Those impurities were identified as olmesartan acid, 4-acetyl olmesartan, 5-acetyl olmesartan, and dehydro olmesartan.Present work describes the synthesis and characterization of all these four impurities.
科研通智能强力驱动
Strongly Powered by AbleSci AI